Human GPR64 PE-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB7977P
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
Phycoerythrin (Excitation = 488 nm, Emission = 565-605 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 206420
Product Specifications
Immunogen
Chinese hamster ovary cell line CHO-derived recombinant human GPR64
Leu38-Asn64, Glu68-Thr553
Accession # NP_001073328
Leu38-Asn64, Glu68-Thr553
Accession # NP_001073328
Specificity
Detects human GPR64 transfectants in cell-based ELISA and Flow Cytometry.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Scientific Data Images for Human GPR64 PE-conjugated Antibody
Detection of GPR64 in NS0 Cell Line Transfected with Human GPR64 and eGFP by Flow Cytometry.
NS0 cell line transfected with Human GPR64 and eGFP was stained with (A) Mouse Anti-Human GPR64 PE-conjugated Monoclonal Antibody (Catalog # FAB7977P) or (B) Mouse IgG2B PE-conjugated isotype control antibody (Catalog # IC0041P). View our protocol for Staining Membrane-associated Proteins.Applications for Human GPR64 PE-conjugated Antibody
Application
Recommended Usage
Flow Cytometry
10 µL/106 cells
Sample: NS0 Cell Line Transfected with Human GPR64 and eGFP
Sample: NS0 Cell Line Transfected with Human GPR64 and eGFP
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
Supplied in a saline solution containing BSA and Sodium Azide.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Protect from light. Do not freeze.
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: GPR64
Long Name
G Protein-coupled Receptor 64
Alternate Names
EDDM6, HE6, TM7LN2
Gene Symbol
ADGRG2
UniProt
Additional GPR64 Products
Product Documents for Human GPR64 PE-conjugated Antibody
Product Specific Notices for Human GPR64 PE-conjugated Antibody
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...